Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy.

Romano L, Venturi G, Ferruzzi R, Riccio ML, Corsi P, Leoncini F, Vinattieri A, Incandela L, Valensin PE, Zazzi M.

AIDS. 2000 Sep 29;14(14):2204-6. No abstract available.

PMID:
11061664
2.

Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patients.

Geretti AM, Smith M, Osner N, O'Shea S, Chrystie I, Easterbrook P, Zuckerman M.

AIDS. 2001 May 25;15(8):1082-4. No abstract available.

PMID:
11400002
3.

Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B.

Grossman Z, Vardinon N, Chemtob D, Alkan ML, Bentwich Z, Burke M, Gottesman G, Istomin V, Levi I, Maayan S, Shahar E, Schapiro JM; Israel Multi-Center Study Group.

AIDS. 2001 Aug 17;15(12):1453-60. Erratum in: AIDS 2001 Nov 9;15(16):2209.

PMID:
11504976
4.

Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.

Paolucci S, Baldanti F, Campanini G, Zavattoni M, Cattaneo E, Dossena L, Gerna G.

J Med Virol. 2001 Oct;65(2):207-17.

PMID:
11536225
5.

Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B.

Montes B, Vergne L, Peeters M, Reynes J, Delaporte E, Segondy M.

J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):329-36.

PMID:
15097148
6.

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.

Babic DZ, Zelnikar M, Seme K, Vandamme AM, Snoeck J, Tomazic J, Vidmar L, Karner P, Poljak M.

Virus Res. 2006 Jun;118(1-2):156-63. Epub 2006 Jan 18.

PMID:
16417938
7.

Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type 1 in infected individuals in Spain (Galicia).

Pérez-Alvarez L, Cuevas MT, Villahermosa ML, Pedreira JD, Manjón N, Herrero I, López-Calvo S, Delgado E, de Parga EV, Medrano L, Thomson MM, Taboada JA, Nájera R; Spanish Group for Antiretroviral Resistance Studies in Galicia.

J Hum Virol. 2001 Jan-Feb;4(1):35-8. No abstract available.

PMID:
11213931
8.

Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences.

Balotta C, Facchi G, Violin M, Van Dooren S, Cozzi-Lepri A, Forbici F, Bertoli A, Riva C, Senese D, Caramello P, Carnevale G, Rizzardini G, Cremonini L, Monno L, Rezza G, Perno CF, Ippolito G, d'Arminio-Monforte A, Vandamme AM, Moroni M; ICONA Study Group.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):499-505.

PMID:
11511828
9.

Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study.

Verbiest W, Brown S, Cohen C, Conant M, Henry K, Hunt S, Sension M, Stein A, Stryker R, Thompson M, Schel P, Van Den Broeck R, Bloor S, Alcorn T, Van Houtte M, Larder B, Hertogs K.

AIDS. 2001 Mar 30;15(5):647-50. No abstract available.

PMID:
11317005
10.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

11.

Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.

Briones C, Pérez-Olmeda M, Rodríguez C, del Romero J, Hertogs K, Soriano V.

J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):145-50.

PMID:
11242181
12.

Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection.

Ariyoshi K, Matsuda M, Miura H, Tateishi S, Yamada K, Sugiura W.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):336-42.

PMID:
12843744
13.
15.

Low prevalence of antiretroviral resistance among persons recently infected with human immunodeficiency virus in two US cities.

Sullivan PS, Buskin SE, Turner JH, Cheingsong R, Saekhou A, Kalish ML, Jones JL, Respess R, Kovacs A, Heneine W.

Int J STD AIDS. 2002 Aug;13(8):554-8.

PMID:
12194739
16.

Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.

Machado ES, Lambert JS, Watson DC, Afonso AO, da Cunha SM, Nogueira SA, Caride E, Oliveira RH, Sill AM, DeVico A, Tanuri A.

J Clin Virol. 2004 May;30(1):24-31.

PMID:
15072750
17.

HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort.

Alexander CS, Dong W, Chan K, Jahnke N, O'Shaughnessy MV, Mo T, Piaseczny MA, Montaner JS, Harrigan PR.

AIDS. 2001 Mar 30;15(5):601-7.

PMID:
11316997
18.

Transmission of HIV-1 variants resistant to the three classes of antiretroviral agents: implications for HIV therapy in primary infection.

Colson P, Ravaux I, Yahi N, Tourrès C, Gallais H, Tamalet C.

AIDS. 2002 Feb 15;16(3):507-9. No abstract available.

PMID:
11834974
19.
20.

Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil.

Barreto CC, Nishyia A, Araújo LV, Ferreira JE, Busch MP, Sabino EC.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):338-41.

PMID:
16540943

Supplemental Content

Support Center